Marine ω-3 Fatty Acid Intake-Reference-Cited by-同舟云学术

Marine ω-3 Fatty Acid Intake

Published:2009-10-19 Issue:1 Volume:33 Page:197-199
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Belalcazar L. Maria¹,Reboussin David M.²,Haffner Steven M.³,Reeves Rebecca S.⁴,Schwenke Dawn C.⁵,Hoogeveen Ron C.⁴,Pi-Sunyer F. Xavier⁶,Ballantyne Christie M.⁴⁷,

Affiliation:

1. Department of Medicine, University of Texas Medical Branch, Galveston, Texas;

2. Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina;

3. Department of Medicine, University of Texas Health Science Center, San Antonio, Texas;

4. Department of Medicine, Baylor College of Medicine, Houston, Texas;

5. Arizona State University, Tempe, Arizona;

6. Department of Medicine, Columbia University, St. Luke's-Roosevelt Hospital, New York, New York;

7. The Methodist Hospital, Houston, Texas.

Abstract

OBJECTIVE To examine usual marine ω-3 fatty acid (mO-3FA) intake in individuals with diabetes; its association with adiposity, lipid, and glucose control; and its changes with behavioral lifestyle intervention for weight loss. RESEARCH DESIGN AND METHODS Cross-sectional and 1-year longitudinal analyses were performed on 2,397 Look AHEAD (Action for Health in Diabetes) participants. Look AHEAD is a cardiovascular outcome trial evaluating the effects of intensive lifestyle intervention for weight loss in overweight/obese subjects with type 2 diabetes. RESULTS Baseline mO-3FA intake was 162 ± 138 mg/day. It was inversely associated with triglycerides (β = −0.41, P < 0.001) and weakly with HDL (β = 4.14, P = 0.050), after multiple covariate adjustment. One-year mO-3FA and fried/sandwich fish intake decreased with intensive lifestyle intervention (P < 0.001). CONCLUSIONS mO-3FA intake in Look AHEAD participants was low but associated favorably with lipids. These results encourage investigation on the potential benefits of increasing mO-3FA intake in lifestyle interventions for weight loss in individuals with diabetes.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/33/1/197/604509/zdc00110000197.pdf

Reference12 articles.

1. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease;Erkkilä;Am J Clin Nutr,2004

2. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus;Glauber;Ann Intern Med,1988

3. Action for Health in Diabetes (Look AHEAD) trial: baseline evaluation of selected nutrients and food group intake;Vitolins;J Am Diet Assoc,2009

4. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes;Ryan;Control Clin Trials,2003

5. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial;Look AHEAD Research Group;Diabetes Care,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood biomarkers of various dietary patterns correlated with metabolic indicators in Taiwanese type 2 diabetes;FOOD NUTR RES;2019

2. Long chain polyunsaturated fatty acids (LCPUFAs) and nordihydroguaiaretic acid (NDGA) modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model (Stillman Salgado rats);Lipids in Health and Disease;2016-11-25

3. Fatty acid intake and metabolic syndrome among overweight and obese women;Revista Brasileira de Epidemiologia;2015-12

4. Does Fish Oil Have an Anti-Obesity Effect in Overweight/Obese Adults? A Meta-Analysis of Randomized Controlled Trials;PLOS ONE;2015-11-16

5. Effects of extra virgin olive oil and fish oil on lipid profile and oxidative stress in patients with metabolic syndrome;Nutrition;2015-06